SCHEMBL4731046

SCHEMBL4731046

CCC(CC)c1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ADRA2A P08913 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
ESR1 P03372 2/20 0.43
ESR2 Q92731 1/20 0.43
CYP2A6 P11509 1/20 0.42
HTR2A P28223 1/20 0.41
CYP1A2 P05177 3/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PYCR1 P32322 1/20 0.38
RAB9A P51151 1/20 0.36
LMNA P02545 1/20 0.36
PGR P06401 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18719647 0.86 ESR1 (0.44) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL8164326 0.86 HDAC8 (0.44) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL3857347 0.86 HDAC8 (0.44) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL20036515 0.83 NR1I2 (0.50) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL13210867 0.83 HDAC8 (0.42) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL27642755 0.83 HDAC8 (0.38) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL19524889 0.83 TRPA1 (0.38) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL18896172 0.83 NR1I2 (0.50) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL18801388 0.81 NR1I2 (0.57) HDAC8HDAC6ADRA2AADRA2BADRA2C
SCHEMBL19901495 0.80 ESR1 (0.47) ESR1ESR2CYP2A6HTR2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106928253-A A kind of preparation method of pinoxaden 武汉工程大学 2017-07-07 CN claimed
CN-111362833-B Double anthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof 陕西师范大学 2023-04-25 CN disclosed
WO-2021061823-A1 CHEMICAL COMPOUNDS Boragen, Inc. (US) 2021-04-01 WO disclosed
WO-2021061823-A1 CHEMICAL COMPOUNDS Boragen, Inc. (US) 2021-04-01 WO disclosed
CN-111362833-A Dianthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof 陕西师范大学 2020-07-03 CN disclosed
CN-110627831-A Bibiaryl acetal phosphines, their preparation and use in coupling reactions 东莞市均成高新材料有限公司 2019-12-31 CN disclosed
US-20190343826-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. 2019-11-14 US disclosed
EP-3209296-B1 ETHYL N-BOC PIPERIDINYL PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME (US) 2019-07-10 EP disclosed
CN-109912457-A A kind of preparation method of 2,6- diethyl -4- aminomethyl phenyl malononitrile 浙江中山化工集团股份有限公司 2019-06-21 CN disclosed
CN-109336762-A The synthetic method of 2- (2,6- diethyl -4- methylbenzene) diethyl malonate 江苏富鼎化学有限公司 2019-02-15 CN disclosed
US-9833421-B2 Method for synthesizing (E)-anethol and related compounds by cross coupling reaction of potassium allyltrifluroborate and 4-bromoanisole and aryl halides TENNESSEE BOARD OF REGENTS (US) 2017-12-05 US disclosed
EP-2520570-A1 AMINOPYRIDINE COMPOUND Ube Industries, Ltd. (JP) 2012-11-07 EP disclosed
US-20120259123-A1 AMINOPYRIDINE COMPOUND UBE INDUSTRIES, LTD. (JP) 2012-10-11 US disclosed
CN-102666490-A Aminopyridine compound UBE INDUSTRIES 2012-09-12 CN disclosed
WO-2008033455-A2 BIPHENYL AND HETEROARYL PHENYL DERIVATIVES AS PROTEIN TYROSINE PHOSPHATASES INHIBITORS THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190343826-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 HDAC8 320/4885HDAC6 177/4885ADRA2A 3967/4885
US-20120259123-A1 AMINOPYRIDINE COMPOUND PTGIS, QDPR, PTGIR HDAC8 3651/4885HDAC6 2572/4885ADRA2A 266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.